The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1342
Tranexamic Acid (Lysteda) for Treatment of Menorrhagia
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Tranexamic Acid (Lysteda) for Treatment of Menorrhagia
The FDA has approved the use of tranexamic acid (Lysteda – Ferring), an oral antifibrinolytic, for treatment of menorrhagia. Tranexamic acid has been used for this purpose in Europe for decades, and is available without a prescription in some...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Tranexamic Acid (Lysteda) for Treatment of Menorrhagia
Article code: 1342b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.